Skip to content

Clinical trials

Active, not recruiting Retinal Degeneration trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Retinal Degeneration Status: Active, not recruiting Country / region: United States Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20121
20151
20182
20203
20213
20221
20235
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting19

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Beacon Therapeutics4
AbbVie2
Nanoscope Therapeutics Inc.2
National Eye Institute (NEI)2
Adverum Biotechnologies, Inc.1
Cedars-Sinai Medical Center1
Complement Therapeutics1
Elisigen, Inc.1
GenSight Biologics1
Jaeb Center for Health Research1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Retinal Degeneration19
Eye Diseases9
Retinal Diseases9
Eye Diseases, Hereditary5
Macular Degeneration5
Retinal Dystrophies5
Retinitis Pigmentosa5
Choroidal Neovascularization4
Wet Macular Degeneration4
Cone-Rod Dystrophies2

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.